Rohit Sood, Executive Vice President at EVERSANA discusses the increase in first-time launchers, the reasons behind their failure rates, and lessons to be learned from big pharma launches. They also touch on adapting to circumstances and strategy, ownership incentives for first-timers, emerging markets, and the importance of lifelong learning in pharma marketing.